Logo do repositório
 
Publicação

CVOT summit report 2024

2025-05Outro Acesso aberto
Ver registo simples
dc.contributor.authorSchnell, Oliver
dc.contributor.authorAlmandoz, Jaime
dc.contributor.authorAnderson, Lisa
dc.contributor.authorBarnard-Kelly, Katharine
dc.contributor.authorBattelino, Tadej
dc.contributor.authorBlüher, Matthias
dc.contributor.authorBusetto, Luca
dc.contributor.authorCatrinou, Doina
dc.contributor.authorCeriello, Antonio
dc.contributor.authorCos, Xavier
dc.contributor.authorDanne, Thomas
dc.contributor.authorDayan, Colin M.
dc.contributor.authorDel Prato, Stefano
dc.contributor.authorFernández-Fernández, Beatriz
dc.contributor.authorFioretto, Paola
dc.contributor.authorForst, Thomas
dc.contributor.authorGavin, James R.
dc.contributor.authorGiorgino, Francesco
dc.contributor.authorGroop, Per Henrik
dc.contributor.authorHarsch, Igor A.
dc.contributor.authorHeerspink, Hiddo J.L.
dc.contributor.authorHeinemann, Lutz
dc.contributor.authorIbrahim, Mahmoud
dc.contributor.authorJadoul, Michel
dc.contributor.authorJarvis, Sarah
dc.contributor.authorJi, Linong
dc.contributor.authorKanumilli, Naresh
dc.contributor.authorKosiborod, Mikhail
dc.contributor.authorLandmesser, Ulf
dc.contributor.authorMacieira, Sofia
dc.contributor.authorMankovsky, Boris
dc.contributor.authorMarx, Nikolaus
dc.contributor.authorMathieu, Chantal
dc.contributor.authorMcGowan, Barbara
dc.contributor.authorMilenkovic, Tatjana
dc.contributor.authorMoser, Othmar
dc.contributor.authorMüller-Wieland, Dirk
dc.contributor.authorPapanas, Nikolaos
dc.contributor.authorPatel, Dipesh C.
dc.contributor.authorPfeiffer, Andreas F.H.
dc.contributor.authorRahelić, Dario
dc.contributor.authorRodbard, Helena W.
dc.contributor.authorRydén, Lars
dc.contributor.authorSchaeffner, Elke
dc.contributor.authorSpearman, C. Wendy
dc.contributor.authorStirban, Alin
dc.contributor.authorTacke, Frank
dc.contributor.authorTopsever, Pinar
dc.contributor.authorVan Gaal, Luc
dc.contributor.authorStandl, Eberhard
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblSpringer Verlag
dc.date.accessioned2025-05-27T21:23:50Z
dc.date.available2025-05-27T21:23:50Z
dc.date.issued2025-05
dc.description.abstractThe 10th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on December 5–6, 2024. This year, discussions about cardiovascular (CV) and kidney outcome trials centered on the recent findings from studies involving empagliflozin (EMPACT-MI), semaglutide (STEP-HFpEF-DM and FLOW), tirzepatide (SURMOUNT-OSA and SUMMIT), and finerenone (FINEARTS-HF). These studies represent significant advances in reducing the risk of major adverse cardiovascular events (MACE) and improving metabolic outcomes in heart failure with preserved ejection fraction (HFpEF), chronic kidney disease (CKD), and obstructive sleep apnea (OSA). The congress also comprised sessions on novel and established therapies for managing HFpEF, CKD, and obesity; guidelines for managing CKD and metabolic dysfunction-associated steatotic liver disease (MASLD); organ crosstalk and the development of cardio-kidney-metabolic (CKM) syndrome; precision medicine and person-centered management of diabetes, obesity, cardiovascular disease (CVD) and CKD; early detection of type 1 diabetes (T1D) and strategies to delay its onset; continuous glucose monitoring (CGM) and automated insulin delivery (AID); cardiovascular autonomic neuropathy (CAN) and the diabetic heart; and the role of primary care in the early detection, prevention and management of CKM diseases. The contribution of environmental plastic pollution to CVD risk, the increasing understanding of the efficacy and safety of incretin therapies in the treatment of CKM diseases, and the latest updates on nutrition strategies for CKM management under incretin-based therapies were also topics of interest for a vast audience of endocrinologists, diabetologists, cardiologists, nephrologists and primary care physicians, who actively engaged in online discussions. The 11th CVOT Summit will be held virtually on November 20–21, 2025 (http://www.cvot.org).en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent1499673
dc.identifier.doi10.1186/s12933-025-02700-0
dc.identifier.issn1475-2840
dc.identifier.otherPURE: 116079069
dc.identifier.otherPURE UUID: 85b89f7a-4d0e-47d8-bb69-630de12f70e6
dc.identifier.otherScopus: 105004355871
dc.identifier.urihttp://hdl.handle.net/10362/183511
dc.identifier.urlhttps://www.scopus.com/pages/publications/105004355871
dc.language.isoeng
dc.peerreviewedyes
dc.subjectCardiovascular disease
dc.subjectCGM
dc.subjectChronic kidney disease
dc.subjectCKM
dc.subjectDiabetes
dc.subjectFinerenone
dc.subjectGLP-1 RA
dc.subjectGuidelines
dc.subjectHeart failure
dc.subjectMASLD
dc.subjectObesity
dc.subjectSGLT2 inhibitor
dc.subjectTirzepatide
dc.subjectInternal Medicine
dc.subjectEndocrinology, Diabetes and Metabolism
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleCVOT summit report 2024en
dc.title.subtitlenew cardiovascular, kidney, and metabolic outcomesen
dc.typeother
degois.publication.issue1
degois.publication.titleCardiovascular Diabetology
degois.publication.volume24
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
s12933-025-02700-0.pdf
Tamanho:
1.43 MB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS - Artigos em revista internacional com arbitragem científica